Skip to application
All calculators and tools

Preparation. Administration. Evidence.

IV Dilution &
Medication Reference

Search 255 medications, read preserved historical references, and inspect separately reviewed preparation statements. Full monograph updates remain pending.

Version 6.4Release date 2026-11-04For healthcare professionals
Back to resultsA-Z list

Medication reference

Adenosine

Monograph awaiting updateThis monograph will be updated in the future.

Jump to a section
Search DailyMed products (opens in a new tab)

No original site article was mapped to this record. The available historical structured fields and official-source links are retained.

Historical first look: uses, mechanism, dosing context, and administration

Recovered v5.1 source content; historical, awaiting current review.

Id
adenosine
Source IDH51-9DF3E9D606C970F16ED9D902
Generic name
Adenosine
Source IDH51-0111932EEF7E722E816D6F39
Class
Cardiovascular and vasoactive
Source IDH51-9794A6619F607A97A85A5695
Subclass
Antiarrhythmic
Source IDH51-52824C84C89596E28C083B37
Primary uses
  1. Regular narrow-complex SVT
    Source IDH51-387D42EA2BFACA1CBFF845F6
  2. Diagnostic use in selected wide-complex tachycardia
    Source IDH51-F59B334999764C502FFA12F2
Mechanism
Activates A1 receptors in the atrioventricular node and transiently suppresses AV nodal conduction.
Source IDH51-ED44A722CB95745A67C6344C
Mechanism level
drug_specific
Source IDH51-57C283F7358EFB83CE0C5343
Basic dosing orientation
Adult / Pediatric | Adult: 6 mg, then 12 mg if needed; pediatric: 0.1 mg/kg then 0.2 mg/kg per resuscitation protocol | Adult: 6 mg, then 12 mg if needed; pediatric: 0.1 mg/kg then 0.2 mg/kg per resuscitation protocol | Patient- and indication-specific | See current package insert | IV push
Source IDH51-C12094F1868F7BEEAA73DF56
Administration orientation
Rapid IV push over 1 to 2 seconds followed immediately by rapid NS flush; 3 mg/mL ready-to-use syringe or vial; Rapid IV push over 1 to 2 seconds followed immediately by rapid NS flush
Source IDH51-02864A612E60BDF8CF1E88EC
Renal and population orientation
Separate renal reference: Open Renal Dosing Master (opens in a new tab)Renal dosing status has not been locally normalized; use the current package insert before ordering or administration.
Source IDH51-467C78F6C3D318BF7F5D73F6
Key safety orientation
  1. Transient asystole, heart block, bronchospasm, chest discomfort, and atrial fibrillation.
    Source IDH51-56BF15ED76FD5BD859094DF5
  2. Do not use for irregular/polymorphic wide-complex tachycardia.
    Source IDH51-8FDA080F1F8A6C7E52115FBC
Coverage path
structured_local_snapshot
Source IDH51-04ABFB53AF7F765A20062C0C
Coverage path label
Structured GlobalRPh route snapshot
Source IDH51-11393279FF864AFE9E4F9A4C
Review note
First-look orientation only. Verify indication, patient population, weight basis, organ function, exact IV product, dose, concentration, compatibility, rate, and current labeling before use.
Source IDH51-B468FFA6C5254C4C4A19FFC8
Search text
Adenosine Cardiovascular and vasoactive Antiarrhythmic Regular narrow-complex SVT Diagnostic use in selected wide-complex tachycardia Activates A1 receptors in the atrioventricular node and transiently suppresses AV nodal conduction. Adult / Pediatric | Adult: 6 mg, then 12 mg if needed; pediatric: 0.1 mg/kg then 0.2 mg/kg per resuscitation protocol | Adult: 6 mg, then 12 mg if needed; pediatric: 0.1 mg/kg then 0.2 mg/kg per resuscitation protocol | Patient- and indication-specific | See current package insert | IV push Rapid IV push over 1 to 2 seconds followed immediately by rapid NS flush; 3 mg/mL ready-to-use syringe or vial; Rapid IV push over 1 to 2 seconds followed immediately by rapid NS flush Renal dosing status has not been locally normalized; use the current package insert before ordering or administration. Transient asystole, heart block, bronchospasm, chest discomfort, and atrial fibrillation. Do not use for irregular/polymorphic wide-complex tachycardia. Structured GlobalRPh route snapshot
Source IDH51-235BD4C9C5B1D810A4420F0F
Official access mode
search
Source IDH51-7C5D630F875F623D3C50F987
Official search query
Adenosine
Source IDH51-31C599D7042D2320EB445F6B
Official access reason
A source-backed DailyMed search is available; select and confirm the exact IV product.
Source IDH51-299B429B5728D6986522B246
Product identifiers and clinical review status

This monograph will be updated in the future. Historical material is available where present in the original sources; full current exact-product and claim-level review remains pending.

Exact formulation, concentration, container, manufacturer, regulatory identifiers, and a reproducible label snapshot have not all been reconciled.

What remains to be completed
  • Retrievable exact-product SPL XML with version, revision, retrieval date and reproducible hash
  • Clinically reviewed, individually identified statements with two exact source mappings
  • Exact formulation, strength, container, manufacturer/labeler, application and NDC reconciliation
  • Renal-function methods and dialysis/CRRT modality review where applicable
  • Mechanism provenance, clinical source disagreements and full medication-specific safety reconciliation

Supplemental historical fields

Restored-data provenance and review notes

Source release: 2026-08-31. Current clinical review is incomplete. Original uses of current, verified, or normalized describe the historical source. They do not inherit the status of separately reviewed statements. Product formulations and source dates can differ.

Current review annotations for historical renal, dialysis, mechanism, and product fieldsSeparate renal reference: Open Renal Dosing Master (opens in a new tab)
Renal
Status
not_locally_normalized
Original classification
current_label_review_required
Entries
    General note
    Preserve the source-specific renal-function basis. An indexed CrCl table is not interchangeable with unindexed CrCl or eGFR. Generic advice to check a method does not identify the equation for a dose row.
    Dialysis
    Status
    no_local_structured_regimen
    Entries
      General note
      Named modality alone does not establish applicability. CRRT subtype, effluent rate, residual renal function, timing and interruptions require review. Historical absence is not evidence that no guidance exists.
      Mechanisms
      • Source kind
        first_look
        Local pointer
        /mechanism
        Original level
        drug_specific
        Provenance classification
        historical_drug_specific_uncorroborated
        Label derived verified
        false
        Independently corroborated
        false
        Exact label section
        Not recorded
        Original source note
        Not recorded
        Review status
        historical_unverified
        Note
        Drug-specific wording in the old file is not proof of independent corroboration or an exact label locator. Consult separately published current mechanism claims where present.
      Future update
      Status
      pending_review
      Message
      This monograph will be updated in the future as current exact-product and claim-level review is completed.
      Source unavailable
      false
      Reason
      The historical content is restored; comprehensive contemporary verification remains incomplete.

      No separate structured rows were bundled for preparation, continuous infusion, dialysis, CRRT. Historical article content and source links may cover these topics.

      Historical IV-push guidance

      Recovered v5.1 source content; historical, awaiting current review.

      PopulationDose scopeConcentrationRateStatusNotes
      Source IDH51-3A662FC7DB368ABAC84ADB47
      Adult / Pediatric
      Source IDH51-DC2F0C93F08805958350482A
      		Adult: 6 mg, then 12 mg if needed; pediatric: 0.1 mg/kg then 0.2 mg/kg per resuscitation protocol
      Source IDH51-8CA21EE9AC4A317981BB4ED0
      		3 mg/mL ready-to-use syringe or vial
      Source IDH51-2D3C6D129F09CE02008C4202
      		Rapid IV push over 1 to 2 seconds followed immediately by rapid NS flush
      Source IDH51-2863963800F179D7F5B9DB33
      		Use only when ordered and supported by current labeling or institutional policy
      Source IDH51-D881D2C11F245F3CE1A780B4
      		Use the most proximal patent line and continuous ECG recording. Dose reduction may be needed with central-line administration or transplant; higher dose may be needed with methylxanthines.
      Source IDH51-78663196804BF43C0ED2BEC7

      Historical indication and population dosing

      Recovered tables and source-separated snapshots; full clinical revalidation remains pending.

      Existing dose and route snapshots

      RoutePopulationIndicationDoseIntervalDurationAdministrationSource levelNotes
      Source IDH51-C337E114DBB5D3D3D94B4FA8
      IV push
      Source IDH51-28661483CD0B73EA763EED12
      		Adult / Pediatric
      Source IDH51-1F7DFC708B4B0D13FC4341F1
      		Adult: 6 mg, then 12 mg if needed; pediatric: 0.1 mg/kg then 0.2 mg/kg per resuscitation protocol
      Source IDH51-A24C9379BBE1E5B88FCDC2EA
      		Adult: 6 mg, then 12 mg if needed; pediatric: 0.1 mg/kg then 0.2 mg/kg per resuscitation protocol
      Source IDH51-73A9FF9060BBCB22823B51C5
      		Patient- and indication-specific
      Source IDH51-B07D5EDED871FE7095F76201
      		See current package insert
      Source IDH51-57447C7E1DB170243CDEB527
      		Rapid IV push over 1 to 2 seconds followed immediately by rapid NS flush
      Source IDH51-2B32CEC129853F7AA8D4BA0D
      		Existing GlobalRPh IV push snapshot
      Source IDH51-7DFA583AD697A4467AFE5656
      		Use only when ordered and supported by current labeling or institutional policy Use the most proximal patent line and continuous ECG recording. Dose reduction may be needed with central-line administration or transplant; higher dose may be needed with methylxanthines.
      Source IDH51-F9FC5A9E025057ECC755FAFB

      Historical renal-function guidance

      Recovered v5.1 source content; historical, awaiting current review.

      Separate renal reference: Open Renal Dosing Master (opens in a new tab)
      Classification
      current_label_review_required
      Source IDH51-8A6DDFE2411A706AFECDB9DA
      Summary
      Renal dosing status has not been locally normalized; use the current package insert before ordering or administration.
      Source IDH51-B99F934673B5394127CA3225
      Method note
      Use the renal function estimate and body-size convention specified by the selected label or institutional protocol. Do not interchange Cockcroft-Gault CrCl, indexed eGFR, and de-indexed eGFR without confirming the dosing source.
      Source IDH51-CD9EE24AE492C459B7BE4839

      Historical Common IV uses

      Recovered v5.1 source content; historical, awaiting current review.

      1. Regular narrow-complex SVT
        Source IDH51-E01AD56D3924C85EE36F1C95
      2. Diagnostic use in selected wide-complex tachycardia
        Source IDH51-EDB615C7A626BFDBD096A3CB

      Historical Warnings and safeguards

      Recovered v5.1 source content; historical, awaiting current review.

      1. Transient asystole, heart block, bronchospasm, chest discomfort, and atrial fibrillation.
        Source IDH51-DDF8BB0DCF675057EC88AD6F
      2. Do not use for irregular/polymorphic wide-complex tachycardia.
        Source IDH51-EB752AF0E41141142C764859

      Historical Monitoring

      Recovered v5.1 source content; historical, awaiting current review.

      1. Continuous ECG
        Source IDH51-099D0BA8A86A67928C54688A
      2. Blood pressure and rhythm response
        Source IDH51-11D002DD2118111EBC20E520
      Other recovered source fields and original editorial metadata

      Original status words such as current, verified, or normalized describe the historical source release. They do not change the clinical review status of this release.

      Catalog source fields

      Id
      adenosine
      Source IDH51-A415D1AF38EBD02E7FAE9325
      Generic name
      Adenosine
      Source IDH51-FE0F4CB5722A6F5561AE7346
      Brand names
      1. Adenocard
        Source IDH51-167A4AEB90AECE923449FC2F
      Class
      Cardiovascular and vasoactive
      Source IDH51-DBE1ABCD8E61BBF97498182A
      Subclass
      Antiarrhythmic
      Source IDH51-C38273E7D90D4727397434BF
      Summary
      Very short-acting AV nodal blocker that requires rapid proximal IV delivery followed immediately by a flush.
      Source IDH51-2415C8662E253E1B86B900EC
      Populations
      1. Adult
        Source IDH51-DEF985B8FFED44DDABE8BB4B
      2. Pediatric
        Source IDH51-C88764E5C57F2C5DBC45E230
      Evidence tier
      IV push safety normalization - verify stocked product
      Source IDH51-1A9921334299AB660CA2093C
      High alert
      true
      Source IDH51-7D6F488CDA135692AA156A40
      Hazardous
      false
      Source IDH51-E906982BA42F1191E1B24210
      Status
      Active
      Source IDH51-0EC642DE899290FED26EAABD
      Reviewed
      2026-08-29
      Source IDH51-156F1517DEF336491D638705
      Version added
      1.2
      Source IDH51-351874FF19192B4ED0F97848
      Sources
      LabelUrlKind
      Source IDH51-79452123E0827333FB207848
      DailyMed label search
      Source IDH51-C6E8933AF115CC9314D56770
      		https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Adenosine (opens in a new tab)
      Source IDH51-565B8DDB2CFDF0AF2312BE46
      		Primary
      Source IDH51-8D0AE164212A44CC6AF24CDB
      Source IDH51-6A814A45A8606DC33EA7646E
      GlobalRPh legacy IV dilution monograph
      Source IDH51-104AD5BDE15C077DEA07CDC3
      		legacy:auto
      Source IDH51-8CAB082EAEB093C4C2416193
      		Legacy
      Source IDH51-E0BD2EC22CDB6128B57AD280
      Clinical release verification
      Audit version
      3.4
      Source IDH51-CAA6077F5ABA45BDA02DC947
      Audited on
      2026-08-30
      Source IDH51-56FD96C027B1838FB8D29692
      Level
      amber
      Source IDH51-62DD3BD704AC5EF38338D78D
      Release gate
      trusted_professional_source_present_exact_label_unconfirmed
      Source IDH51-CCF7EAF43E6F1831AFEB6139
      Exact current label candidate
      false
      Source IDH51-8DB91E3859D45909C62F6B33
      Numeric support ratio
      0
      Source IDH51-DE4544DC8CD8F4DBA811BFB6
      Reference url count
      1
      Source IDH51-D74C09D8590E1779C45CE480
      Broken reference count
      0
      Source IDH51-D7DCEE3FE7836810C659C6EA
      Point of use confirmation required
      true
      Source IDH51-16F320782D3BAE08C9C5292F
      Note
      Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
      Source IDH51-AD2ABF20F3F3C4EEF4A14856

      Dosing source fields

      Id
      adenosine
      Source IDH51-1812A754FC177C5371D68801
      Generic name
      Adenosine
      Source IDH51-3E2B4DD1D237470E8DC1E9BA
      Coverage status
      direct_official_label_access_plus_local_snapshot
      Source IDH51-8D5B67E037899F8E9E92CFCC
      Package insert
      Query name
      Adenosine
      Source IDH51-051F14B496AAEB74638A18D6
      Product and route must match
      true
      Source IDH51-4636FBBF8626A6BEB59F0DCB
      Live current label enabled
      false
      Source IDH51-7280C105FB47DDADF11A5F62
      Source priority
      Reviewed local summary when available, then a verified DailyMed label or product search when available, followed by professional references and institutional policy.
      Source IDH51-FAC558F7373B21ED0B0B849E
      Direct official label access enabled
      true
      Source IDH51-DC8DE24EA44DBF2567F94E21
      Outbound server request required
      false
      Source IDH51-7792B737C7902DADDCFC2E6B
      Local summary status
      not_bundled
      Source IDH51-5669F1B7A2D3D2FF18E18971
      Clinical review
      Locally normalized
      false
      Source IDH51-8708769772D704201D7D00AB
      Reviewed
      2026-08-29
      Source IDH51-F5B5D0712FC23CE93FD08D0B
      Status
      Direct official package-insert access enabled; indication-specific local normalization pending.
      Source IDH51-292353655665183E63909692
      Clinical release verification
      Audit version
      3.4
      Source IDH51-DD6079BFE8B78E02F9832700
      Audited on
      2026-08-30
      Source IDH51-0678B3C384EF691E17A68BC5
      Level
      amber
      Source IDH51-3F3F302EA344BFCA03E692ED
      Release gate
      trusted_professional_source_present_exact_label_unconfirmed
      Source IDH51-EB18D6A010F2B21B8201F44E
      Exact current label candidate
      false
      Source IDH51-4F0F8A628FBE1228A0895E48
      Numeric support ratio
      0
      Source IDH51-E8C19256AB51EB4F774F3F91
      Reference url count
      1
      Source IDH51-72F470BF872313B21B48BBB4
      Broken reference count
      0
      Source IDH51-37D199AB5544D7A00FA10139
      Point of use confirmation required
      true
      Source IDH51-039C297410E107DBAAC3B048
      Note
      Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
      Source IDH51-4D91F0132FE72420BBBB07A0
      Historical preparation assessment

      Recovered v5.1 source content; historical, awaiting current review.

      Id
      adenosine
      Source IDH51-1BF47712F7EEE031252671FC
      Name
      Adenosine
      Source IDH51-1FC83AB6627E830893B859DD
      Brands
      Adenocard
      Source IDH51-A012E96AC29F74C292A11906
      Therapeutic class
      Cardiovascular and vasoactive
      Source IDH51-C0C4EA40F6BB459457FB5BEA
      Review version
      3.1
      Source IDH51-595F01888CEE6A835824BB38
      Review date
      2026-08-30
      Source IDH51-BFCB2E0DC968411156AA3686
      Release status
      no_released_dilution_current_label_review_required
      Source IDH51-AD8619E161795F825C48319A
      Market status
      Status
      no_current_us_iv_spl_confirmed
      Source IDH51-1C2181967BBDF118DAEA0597
      Basis
      No high-confidence current IV SPL was automatically selected; legacy information is segregated
      Source IDH51-CB7F2EBCCFE77AC121508663
      Ten point assessment
      Exact formulation
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-20E24A0E747964ADACFCEEB7
      Reconstitution concentration
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-FA0B702606E2F9D1E7E6E4B0
      Maximum or recommended final concentration
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-8A21776B0E79470EAEE351F6
      Appropriate standardized containers
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-16DD8DDD2C45169659F332F9
      Adult dosing range
      Adult: 6 mg, then 12 mg if needed; pediatric: 0.1 mg/kg then 0.2 mg/kg per resuscitation protocol Adult: 6 mg, then 12 mg if needed; pediatric: 0.1 mg/kg then 0.2 mg/kg per resuscitation protocol
      Source IDH51-C3CB9DDE50FA2DB203CD26F6
      Pediatric dosing range
      Separate renal reference: Open Renal Dosing Master (opens in a new tab)Do not interchange Cockcroft-Gault CrCl, indexed eGFR, and de-indexed eGFR without confirming the dosing source. | existing_route_snapshots: route: IV push | population: Adult / Pediatric | indication: Adult: 6 mg, then 12 mg if needed; pediatric: 0.1 mg/kg then 0.2 mg/kg per resuscitation protocol | dose: Adult: 6 mg, then 12 mg if needed; pediatric: 0.1 mg/kg then 0.2 mg/kg per resuscitation protocol | interval: Patient- and indication-specific | duration: See current package insert | administration: Rapid IV push over 1 to 2 seconds followed immediately by rapid NS flush | source_level: Existing GlobalRPh IV push snapshot | notes: Use only when ordered and supported by current labeling or institutional policy Use the most proximal patent line and continuous ECG recording. Dose reduction may be needed with central-line administration or transplant; higher dose may be needed with methylxanthines. | warnings: Transient asystole, heart block, bronchospasm, chest discomfort, and atrial fibrillation. | Do not use for irregular/polymorphic wide-complex tachycardia. | monitoring: Continuous ECG | Blood pressure and rhythm response | populations: Adult | Pediatric | evidence_tier: IV push safety normalization - verify stocked product | high_alert: true | hazardous: false | status: Active | reviewed: 2026-08-29 | version_added: 1.2 | sources: label: DailyMed label search | url: https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Adenosine | kind: Primary | label: GlobalRPh legacy IV dilution monograph | url: legacy:auto | kind: Legacy
      Source IDH51-FE384C1BD3F6FC92D7FC0642
      Neonatal dosing range
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-34DAAFD582485043C8626FF5
      Infusion time
      Rapid IV push over 1 to 2 seconds followed immediately by rapid NS flush
      Source IDH51-D51831CAA6C85CEA0D1E04D4
      Fluid restriction alternatives
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-C6BDB41FD8B74F4D0B504D37
      Current manufacturer labeling
      Match confidence
      unresolved
      Source IDH51-278BEB322EF00FBDAB2A245C
      Field provenance
      Exact formulation
      Primary
      not_found
      Source IDH51-C119691BD2AB5163EB5A95F9
      Reconstitution concentration
      Primary
      not_found
      Source IDH51-30E76657D05B35CBF0100EAF
      Maximum or recommended final concentration
      Primary
      not_found
      Source IDH51-94861BE2CF81DFDCBE14E694
      Appropriate standardized containers
      Primary
      not_found
      Source IDH51-80B39DEC84E59F29BF357A3C
      Adult dosing range
      Primary
      existing_structured_record
      Source IDH51-1D4434FA283A53EA6FEF83F7
      Pediatric dosing range
      Primary
      existing_record_text
      Source IDH51-1A6499E1ED78C3ECF3F56683
      Neonatal dosing range
      Primary
      not_found
      Source IDH51-36BA995FB03B287A9FE12DF5
      Infusion time
      Primary
      existing_structured_record
      Source IDH51-0F999A088478E726366647C0
      Fluid restriction alternatives
      Primary
      not_found
      Source IDH51-811E73BD6E1E3FE12D503265
      Current manufacturer labeling
      Primary
      DailyMed search gateway
      Source IDH51-4FC0D65E6CDA8FBAEF507648
      Population applicability
      Adult
      Applicability
      supported_or_source_present
      Source IDH51-91E4C06DA571ADB7AB1FA8BC
      Guide generation allowed
      true
      Source IDH51-664AD944227958305317C3A4
      Pediatric
      Applicability
      supported_or_source_present
      Source IDH51-C4B53D24ACF01F18B0C797A3
      Guide generation allowed
      false
      Source IDH51-74F509E9A161CE570ECA3CCA
      Neonatal
      Applicability
      not_established
      Source IDH51-3B439D4DB49D128A106BFF22
      Guide generation allowed
      false
      Source IDH51-2CDBA89EE0A4F9236F49B6DC
      Route presence
      Structured dilution
      false
      Source IDH51-982AA96A0A4A4FF41DF95F93
      Iv push
      true
      Source IDH51-0AB1B76D6420540259B2FF12
      Continuous infusion
      false
      Source IDH51-A0A8290B225E1447267ED686
      Pediatric source
      true
      Source IDH51-460034D0FD4B4929393C61A1
      Neonatal source
      false
      Source IDH51-BB3F60F0FC96C35811E5606E
      Legacy reference
      Status
      not_available
      Source IDH51-130597CC57464AE40579E3DD
      Label resolution
      Status
      build_environment_network_unavailable
      Source IDH51-A638F4B3B98535C98C25771E
      Source files
      1. catalog.json
        Source IDH51-B43C11CB93F6CB93ED21B65C
      2. dosing.json
        Source IDH51-6B39BB9F76249078AC9DD8E7
      3. new-in-v1.2.json
        Source IDH51-1184D59C3326164A0A43A84E
      Clinical release note
      Preparation instructions are released only at the evidence level shown. Legacy content remains visibly separate. Exact product, NDC, route, current labeling, and institutional policy must be confirmed.
      Source IDH51-A42386B28A4D4694E8B7E078
      Historical statement IDs and source locations

      These IDs identify recovered source units. They are not evidence-qualified clinical claims.

      Historical IDOriginal source locationStatus
      H51-A415D1AF38EBD02E7FAE9325catalog.json
      /records/6/id      		Historical; current review incomplete
      H51-FE0F4CB5722A6F5561AE7346catalog.json
      /records/6/generic_name      		Historical; current review incomplete
      H51-167A4AEB90AECE923449FC2Fcatalog.json
      /records/6/brand_names/0      		Historical; current review incomplete
      H51-DBE1ABCD8E61BBF97498182Acatalog.json
      /records/6/class      		Historical; current review incomplete
      H51-C38273E7D90D4727397434BFcatalog.json
      /records/6/subclass      		Historical; current review incomplete
      H51-2415C8662E253E1B86B900ECcatalog.json
      /records/6/summary      		Historical; current review incomplete
      H51-E01AD56D3924C85EE36F1C95catalog.json
      /records/6/common_uses/0      		Historical; current review incomplete
      H51-EDB615C7A626BFDBD096A3CBcatalog.json
      /records/6/common_uses/1      		Historical; current review incomplete
      H51-3A662FC7DB368ABAC84ADB47catalog.json
      /records/6/iv_push/0      		Historical; current review incomplete
      H51-DC2F0C93F08805958350482Acatalog.json
      /records/6/iv_push/0/population      		Historical; current review incomplete
      H51-8CA21EE9AC4A317981BB4ED0catalog.json
      /records/6/iv_push/0/dose_scope      		Historical; current review incomplete
      H51-2D3C6D129F09CE02008C4202catalog.json
      /records/6/iv_push/0/concentration      		Historical; current review incomplete
      H51-2863963800F179D7F5B9DB33catalog.json
      /records/6/iv_push/0/rate      		Historical; current review incomplete
      H51-D881D2C11F245F3CE1A780B4catalog.json
      /records/6/iv_push/0/status      		Historical; current review incomplete
      H51-78663196804BF43C0ED2BEC7catalog.json
      /records/6/iv_push/0/notes      		Historical; current review incomplete
      H51-DDF8BB0DCF675057EC88AD6Fcatalog.json
      /records/6/warnings/0      		Historical; current review incomplete
      H51-EB752AF0E41141142C764859catalog.json
      /records/6/warnings/1      		Historical; current review incomplete
      H51-099D0BA8A86A67928C54688Acatalog.json
      /records/6/monitoring/0      		Historical; current review incomplete
      H51-11D002DD2118111EBC20E520catalog.json
      /records/6/monitoring/1      		Historical; current review incomplete
      H51-DEF985B8FFED44DDABE8BB4Bcatalog.json
      /records/6/populations/0      		Historical; current review incomplete
      H51-C88764E5C57F2C5DBC45E230catalog.json
      /records/6/populations/1      		Historical; current review incomplete
      H51-1A9921334299AB660CA2093Ccatalog.json
      /records/6/evidence_tier      		Historical; current review incomplete
      H51-7D6F488CDA135692AA156A40catalog.json
      /records/6/high_alert      		Historical; current review incomplete
      H51-E906982BA42F1191E1B24210catalog.json
      /records/6/hazardous      		Historical; current review incomplete
      H51-0EC642DE899290FED26EAABDcatalog.json
      /records/6/status      		Historical; current review incomplete
      H51-156F1517DEF336491D638705catalog.json
      /records/6/reviewed      		Historical; current review incomplete
      H51-351874FF19192B4ED0F97848catalog.json
      /records/6/version_added      		Historical; current review incomplete
      H51-79452123E0827333FB207848catalog.json
      /records/6/sources/0      		Historical; current review incomplete
      H51-C6E8933AF115CC9314D56770catalog.json
      /records/6/sources/0/label      		Historical; current review incomplete
      H51-565B8DDB2CFDF0AF2312BE46catalog.json
      /records/6/sources/0/url      		Historical; current review incomplete
      H51-8D0AE164212A44CC6AF24CDBcatalog.json
      /records/6/sources/0/kind      		Historical; current review incomplete
      H51-6A814A45A8606DC33EA7646Ecatalog.json
      /records/6/sources/1      		Historical; current review incomplete
      H51-104AD5BDE15C077DEA07CDC3catalog.json
      /records/6/sources/1/label      		Historical; current review incomplete
      H51-8CAB082EAEB093C4C2416193catalog.json
      /records/6/sources/1/url      		Historical; current review incomplete
      H51-E0BD2EC22CDB6128B57AD280catalog.json
      /records/6/sources/1/kind      		Historical; current review incomplete
      H51-AEDAFE1F3C355625F97F3F59catalog.json
      /records/6/legacy_title      		Historical; current review incomplete
      H51-CAA6077F5ABA45BDA02DC947catalog.json
      /records/6/clinical_release_verification/audit_version      		Historical; current review incomplete
      H51-56FD96C027B1838FB8D29692catalog.json
      /records/6/clinical_release_verification/audited_on      		Historical; current review incomplete
      H51-62DD3BD704AC5EF38338D78Dcatalog.json
      /records/6/clinical_release_verification/level      		Historical; current review incomplete
      H51-CCF7EAF43E6F1831AFEB6139catalog.json
      /records/6/clinical_release_verification/release_gate      		Historical; current review incomplete
      H51-8DB91E3859D45909C62F6B33catalog.json
      /records/6/clinical_release_verification/exact_current_label_candidate      		Historical; current review incomplete
      H51-EFC4169F1CEBDC5D6DAB73E2catalog.json
      /records/6/clinical_release_verification/selected_setid      		Historical; current review incomplete
      H51-39629D924C1D300805676D59catalog.json
      /records/6/clinical_release_verification/selected_label_title      		Historical; current review incomplete
      H51-DE4544DC8CD8F4DBA811BFB6catalog.json
      /records/6/clinical_release_verification/numeric_support_ratio      		Historical; current review incomplete
      H51-D74C09D8590E1779C45CE480catalog.json
      /records/6/clinical_release_verification/reference_url_count      		Historical; current review incomplete
      H51-D7DCEE3FE7836810C659C6EAcatalog.json
      /records/6/clinical_release_verification/broken_reference_count      		Historical; current review incomplete
      H51-16F320782D3BAE08C9C5292Fcatalog.json
      /records/6/clinical_release_verification/point_of_use_confirmation_required      		Historical; current review incomplete
      H51-AD2ABF20F3F3C4EEF4A14856catalog.json
      /records/6/clinical_release_verification/note      		Historical; current review incomplete
      H51-A23CC8161D2F19CCA44D9B68catalog.json
      /records/6/clinical_release_verification/dailymed_search_url      		Historical; current review incomplete
      H51-1812A754FC177C5371D68801dosing.json
      /records/6/id      		Historical; current review incomplete
      H51-3E2B4DD1D237470E8DC1E9BAdosing.json
      /records/6/generic_name      		Historical; current review incomplete
      H51-8D5B67E037899F8E9E92CFCCdosing.json
      /records/6/coverage_status      		Historical; current review incomplete
      H51-051F14B496AAEB74638A18D6dosing.json
      /records/6/package_insert/query_name      		Historical; current review incomplete
      H51-CF0C568E43D255B9274CD471dosing.json
      /records/6/package_insert/preferred_setid      		Historical; current review incomplete
      H51-4636FBBF8626A6BEB59F0DCBdosing.json
      /records/6/package_insert/product_and_route_must_match      		Historical; current review incomplete
      H51-7280C105FB47DDADF11A5F62dosing.json
      /records/6/package_insert/live_current_label_enabled      		Historical; current review incomplete
      H51-FAC558F7373B21ED0B0B849Edosing.json
      /records/6/package_insert/source_priority      		Historical; current review incomplete
      H51-DC8DE24EA44DBF2567F94E21dosing.json
      /records/6/package_insert/direct_official_label_access_enabled      		Historical; current review incomplete
      H51-7792B737C7902DADDCFC2E6Bdosing.json
      /records/6/package_insert/outbound_server_request_required      		Historical; current review incomplete
      H51-5669F1B7A2D3D2FF18E18971dosing.json
      /records/6/package_insert/local_summary_status      		Historical; current review incomplete
      H51-8A6DDFE2411A706AFECDB9DAdosing.json
      /records/6/renal/classification      		Historical; current review incomplete
      H51-B99F934673B5394127CA3225dosing.json
      /records/6/renal/summary      		Historical; current review incomplete
      H51-CD9EE24AE492C459B7BE4839dosing.json
      /records/6/renal/method_note      		Historical; current review incomplete
      H51-C337E114DBB5D3D3D94B4FA8dosing.json
      /records/6/existing_route_snapshots/0      		Historical; current review incomplete
      H51-28661483CD0B73EA763EED12dosing.json
      /records/6/existing_route_snapshots/0/route      		Historical; current review incomplete
      H51-1F7DFC708B4B0D13FC4341F1dosing.json
      /records/6/existing_route_snapshots/0/population      		Historical; current review incomplete
      H51-A24C9379BBE1E5B88FCDC2EAdosing.json
      /records/6/existing_route_snapshots/0/indication      		Historical; current review incomplete
      H51-73A9FF9060BBCB22823B51C5dosing.json
      /records/6/existing_route_snapshots/0/dose      		Historical; current review incomplete
      H51-B07D5EDED871FE7095F76201dosing.json
      /records/6/existing_route_snapshots/0/interval      		Historical; current review incomplete
      H51-57447C7E1DB170243CDEB527dosing.json
      /records/6/existing_route_snapshots/0/duration      		Historical; current review incomplete
      H51-2B32CEC129853F7AA8D4BA0Ddosing.json
      /records/6/existing_route_snapshots/0/administration      		Historical; current review incomplete
      H51-7DFA583AD697A4467AFE5656dosing.json
      /records/6/existing_route_snapshots/0/source_level      		Historical; current review incomplete
      H51-F9FC5A9E025057ECC755FAFBdosing.json
      /records/6/existing_route_snapshots/0/notes      		Historical; current review incomplete
      H51-8708769772D704201D7D00ABdosing.json
      /records/6/clinical_review/locally_normalized      		Historical; current review incomplete
      H51-F5B5D0712FC23CE93FD08D0Bdosing.json
      /records/6/clinical_review/reviewed      		Historical; current review incomplete
      H51-292353655665183E63909692dosing.json
      /records/6/clinical_review/status      		Historical; current review incomplete
      H51-DD6079BFE8B78E02F9832700dosing.json
      /records/6/clinical_release_verification/audit_version      		Historical; current review incomplete
      H51-0678B3C384EF691E17A68BC5dosing.json
      /records/6/clinical_release_verification/audited_on      		Historical; current review incomplete
      H51-3F3F302EA344BFCA03E692EDdosing.json
      /records/6/clinical_release_verification/level      		Historical; current review incomplete
      H51-EB18D6A010F2B21B8201F44Edosing.json
      /records/6/clinical_release_verification/release_gate      		Historical; current review incomplete
      H51-4F0F8A628FBE1228A0895E48dosing.json
      /records/6/clinical_release_verification/exact_current_label_candidate      		Historical; current review incomplete
      H51-9029A5F925263B942FA0714Bdosing.json
      /records/6/clinical_release_verification/selected_setid      		Historical; current review incomplete
      H51-6F52E50C101D92FA44118287dosing.json
      /records/6/clinical_release_verification/selected_label_title      		Historical; current review incomplete
      H51-E8C19256AB51EB4F774F3F91dosing.json
      /records/6/clinical_release_verification/numeric_support_ratio      		Historical; current review incomplete
      H51-72F470BF872313B21B48BBB4dosing.json
      /records/6/clinical_release_verification/reference_url_count      		Historical; current review incomplete
      H51-37D199AB5544D7A00FA10139dosing.json
      /records/6/clinical_release_verification/broken_reference_count      		Historical; current review incomplete
      H51-039C297410E107DBAAC3B048dosing.json
      /records/6/clinical_release_verification/point_of_use_confirmation_required      		Historical; current review incomplete
      H51-4D91F0132FE72420BBBB07A0dosing.json
      /records/6/clinical_release_verification/note      		Historical; current review incomplete
      H51-D16F3426749918B6CE48D04Adosing.json
      /records/6/clinical_release_verification/dailymed_search_url      		Historical; current review incomplete
      H51-9DF3E9D606C970F16ED9D902first-look-v5.1.json
      /records/6/id      		Historical; current review incomplete
      H51-0111932EEF7E722E816D6F39first-look-v5.1.json
      /records/6/generic_name      		Historical; current review incomplete
      H51-9794A6619F607A97A85A5695first-look-v5.1.json
      /records/6/class      		Historical; current review incomplete
      H51-52824C84C89596E28C083B37first-look-v5.1.json
      /records/6/subclass      		Historical; current review incomplete
      H51-387D42EA2BFACA1CBFF845F6first-look-v5.1.json
      /records/6/primary_uses/0      		Historical; current review incomplete
      H51-F59B334999764C502FFA12F2first-look-v5.1.json
      /records/6/primary_uses/1      		Historical; current review incomplete
      H51-ED44A722CB95745A67C6344Cfirst-look-v5.1.json
      /records/6/mechanism      		Historical; current review incomplete
      H51-57C283F7358EFB83CE0C5343first-look-v5.1.json
      /records/6/mechanism_level      		Historical; current review incomplete
      H51-C12094F1868F7BEEAA73DF56first-look-v5.1.json
      /records/6/basic_dosing_orientation      		Historical; current review incomplete
      H51-02864A612E60BDF8CF1E88ECfirst-look-v5.1.json
      /records/6/administration_orientation      		Historical; current review incomplete
      H51-467C78F6C3D318BF7F5D73F6first-look-v5.1.json
      /records/6/renal_and_population_orientation      		Historical; current review incomplete
      H51-56BF15ED76FD5BD859094DF5first-look-v5.1.json
      /records/6/key_safety_orientation/0      		Historical; current review incomplete
      H51-8FDA080F1F8A6C7E52115FBCfirst-look-v5.1.json
      /records/6/key_safety_orientation/1      		Historical; current review incomplete
      H51-04ABFB53AF7F765A20062C0Cfirst-look-v5.1.json
      /records/6/coverage_path      		Historical; current review incomplete
      H51-11393279FF864AFE9E4F9A4Cfirst-look-v5.1.json
      /records/6/coverage_path_label      		Historical; current review incomplete
      H51-CA1538910750CB4353AAC006first-look-v5.1.json
      /records/6/official_label_url      		Historical; current review incomplete
      H51-8E74074E930AE8F535978944first-look-v5.1.json
      /records/6/legacy_title      		Historical; current review incomplete
      H51-B468FFA6C5254C4C4A19FFC8first-look-v5.1.json
      /records/6/review_note      		Historical; current review incomplete
      H51-235BD4C9C5B1D810A4420F0Ffirst-look-v5.1.json
      /records/6/search_text      		Historical; current review incomplete
      H51-A43406F7965831290DCEAE42first-look-v5.1.json
      /records/6/official_search_url      		Historical; current review incomplete
      H51-7C5D630F875F623D3C50F987first-look-v5.1.json
      /records/6/official_access_mode      		Historical; current review incomplete
      H51-2E8E02EAD7B5AF8DBB5F67ACfirst-look-v5.1.json
      /records/6/official_access_url      		Historical; current review incomplete
      H51-31C599D7042D2320EB445F6Bfirst-look-v5.1.json
      /records/6/official_search_query      		Historical; current review incomplete
      H51-299B429B5728D6986522B246first-look-v5.1.json
      /records/6/official_access_reason      		Historical; current review incomplete
      H51-1BF47712F7EEE031252671FCpreparation-assessments-v3.8.json
      /6/id      		Historical; current review incomplete
      H51-1FC83AB6627E830893B859DDpreparation-assessments-v3.8.json
      /6/name      		Historical; current review incomplete
      H51-A012E96AC29F74C292A11906preparation-assessments-v3.8.json
      /6/brands      		Historical; current review incomplete
      H51-C0C4EA40F6BB459457FB5BEApreparation-assessments-v3.8.json
      /6/therapeutic_class      		Historical; current review incomplete
      H51-595F01888CEE6A835824BB38preparation-assessments-v3.8.json
      /6/review_version      		Historical; current review incomplete
      H51-BFCB2E0DC968411156AA3686preparation-assessments-v3.8.json
      /6/review_date      		Historical; current review incomplete
      H51-AD8619E161795F825C48319Apreparation-assessments-v3.8.json
      /6/release_status      		Historical; current review incomplete
      H51-1C2181967BBDF118DAEA0597preparation-assessments-v3.8.json
      /6/market_status/status      		Historical; current review incomplete
      H51-CB7F2EBCCFE77AC121508663preparation-assessments-v3.8.json
      /6/market_status/basis      		Historical; current review incomplete
      H51-20E24A0E747964ADACFCEEB7preparation-assessments-v3.8.json
      /6/ten_point_assessment/exact_formulation      		Historical; current review incomplete
      H51-FA0B702606E2F9D1E7E6E4B0preparation-assessments-v3.8.json
      /6/ten_point_assessment/reconstitution_concentration      		Historical; current review incomplete
      H51-8A21776B0E79470EAEE351F6preparation-assessments-v3.8.json
      /6/ten_point_assessment/maximum_or_recommended_final_concentration      		Historical; current review incomplete
      H51-16DD8DDD2C45169659F332F9preparation-assessments-v3.8.json
      /6/ten_point_assessment/appropriate_standardized_containers      		Historical; current review incomplete
      H51-C3CB9DDE50FA2DB203CD26F6preparation-assessments-v3.8.json
      /6/ten_point_assessment/adult_dosing_range      		Historical; current review incomplete
      H51-FE384C1BD3F6FC92D7FC0642preparation-assessments-v3.8.json
      /6/ten_point_assessment/pediatric_dosing_range      		Historical; current review incomplete
      H51-34DAAFD582485043C8626FF5preparation-assessments-v3.8.json
      /6/ten_point_assessment/neonatal_dosing_range      		Historical; current review incomplete
      H51-D51831CAA6C85CEA0D1E04D4preparation-assessments-v3.8.json
      /6/ten_point_assessment/infusion_time      		Historical; current review incomplete
      H51-C6BDB41FD8B74F4D0B504D37preparation-assessments-v3.8.json
      /6/ten_point_assessment/fluid_restriction_alternatives      		Historical; current review incomplete
      H51-26431FAEFC17B5F3F1EAFAF5preparation-assessments-v3.8.json
      /6/ten_point_assessment/current_manufacturer_labeling/setid      		Historical; current review incomplete
      H51-A24D29834A78E763D4A14B4Bpreparation-assessments-v3.8.json
      /6/ten_point_assessment/current_manufacturer_labeling/title      		Historical; current review incomplete
      H51-0112F1738E3DAA765AB873E5preparation-assessments-v3.8.json
      /6/ten_point_assessment/current_manufacturer_labeling/published_date      		Historical; current review incomplete
      H51-6AE402A4D351B8E93FEA21E1preparation-assessments-v3.8.json
      /6/ten_point_assessment/current_manufacturer_labeling/manufacturer      		Historical; current review incomplete
      H51-278BEB322EF00FBDAB2A245Cpreparation-assessments-v3.8.json
      /6/ten_point_assessment/current_manufacturer_labeling/match_confidence      		Historical; current review incomplete
      H51-17794E348134C8E58ED9D3C4preparation-assessments-v3.8.json
      /6/ten_point_assessment/current_manufacturer_labeling/url      		Historical; current review incomplete
      H51-C119691BD2AB5163EB5A95F9preparation-assessments-v3.8.json
      /6/field_provenance/exact_formulation/primary      		Historical; current review incomplete
      H51-30E76657D05B35CBF0100EAFpreparation-assessments-v3.8.json
      /6/field_provenance/reconstitution_concentration/primary      		Historical; current review incomplete
      H51-94861BE2CF81DFDCBE14E694preparation-assessments-v3.8.json
      /6/field_provenance/maximum_or_recommended_final_concentration/primary      		Historical; current review incomplete
      H51-80B39DEC84E59F29BF357A3Cpreparation-assessments-v3.8.json
      /6/field_provenance/appropriate_standardized_containers/primary      		Historical; current review incomplete
      H51-1D4434FA283A53EA6FEF83F7preparation-assessments-v3.8.json
      /6/field_provenance/adult_dosing_range/primary      		Historical; current review incomplete
      H51-1A6499E1ED78C3ECF3F56683preparation-assessments-v3.8.json
      /6/field_provenance/pediatric_dosing_range/primary      		Historical; current review incomplete
      H51-36BA995FB03B287A9FE12DF5preparation-assessments-v3.8.json
      /6/field_provenance/neonatal_dosing_range/primary      		Historical; current review incomplete
      H51-0F999A088478E726366647C0preparation-assessments-v3.8.json
      /6/field_provenance/infusion_time/primary      		Historical; current review incomplete
      H51-811E73BD6E1E3FE12D503265preparation-assessments-v3.8.json
      /6/field_provenance/fluid_restriction_alternatives/primary      		Historical; current review incomplete
      H51-4FC0D65E6CDA8FBAEF507648preparation-assessments-v3.8.json
      /6/field_provenance/current_manufacturer_labeling/primary      		Historical; current review incomplete
      H51-91E4C06DA571ADB7AB1FA8BCpreparation-assessments-v3.8.json
      /6/population_applicability/adult/applicability      		Historical; current review incomplete
      H51-664AD944227958305317C3A4preparation-assessments-v3.8.json
      /6/population_applicability/adult/guide_generation_allowed      		Historical; current review incomplete
      H51-C4B53D24ACF01F18B0C797A3preparation-assessments-v3.8.json
      /6/population_applicability/pediatric/applicability      		Historical; current review incomplete
      H51-74F509E9A161CE570ECA3CCApreparation-assessments-v3.8.json
      /6/population_applicability/pediatric/guide_generation_allowed      		Historical; current review incomplete
      H51-3B439D4DB49D128A106BFF22preparation-assessments-v3.8.json
      /6/population_applicability/neonatal/applicability      		Historical; current review incomplete
      H51-2CDBA89EE0A4F9236F49B6DCpreparation-assessments-v3.8.json
      /6/population_applicability/neonatal/guide_generation_allowed      		Historical; current review incomplete
      H51-982AA96A0A4A4FF41DF95F93preparation-assessments-v3.8.json
      /6/route_presence/structured_dilution      		Historical; current review incomplete
      H51-0AB1B76D6420540259B2FF12preparation-assessments-v3.8.json
      /6/route_presence/iv_push      		Historical; current review incomplete
      H51-A0A8290B225E1447267ED686preparation-assessments-v3.8.json
      /6/route_presence/continuous_infusion      		Historical; current review incomplete
      H51-460034D0FD4B4929393C61A1preparation-assessments-v3.8.json
      /6/route_presence/pediatric_source      		Historical; current review incomplete
      H51-BB3F60F0FC96C35811E5606Epreparation-assessments-v3.8.json
      /6/route_presence/neonatal_source      		Historical; current review incomplete
      H51-130597CC57464AE40579E3DDpreparation-assessments-v3.8.json
      /6/legacy_reference/status      		Historical; current review incomplete
      H51-A638F4B3B98535C98C25771Epreparation-assessments-v3.8.json
      /6/label_resolution/status      		Historical; current review incomplete
      H51-B43C11CB93F6CB93ED21B65Cpreparation-assessments-v3.8.json
      /6/source_files/0      		Historical; current review incomplete
      H51-6B39BB9F76249078AC9DD8E7preparation-assessments-v3.8.json
      /6/source_files/1      		Historical; current review incomplete
      H51-1184D59C3326164A0A43A84Epreparation-assessments-v3.8.json
      /6/source_files/2      		Historical; current review incomplete
      H51-A42386B28A4D4694E8B7E078preparation-assessments-v3.8.json
      /6/clinical_release_note      		Historical; current review incomplete
      All medicationsReturn to medication headingApplication top